The Future Burden of Type 2 Diabetes and the Role of Glycaemic Control and GLP1-RAs.

Davies M, Padgett TE, Goulden S, McEwan P, Chubb B, Whitaker J, Khunti K

Open source

DOI
10.1016/j.mayocp.2026.10.021
Published
2026 Nov 3
Container
Mayo Clinic proceedings
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.mayocp.2026.10.021,
  title = {The Future Burden of Type 2 Diabetes and the Role of Glycaemic Control and GLP1-RAs.},
  author = {Davies M and Padgett TE and Goulden S and McEwan P and Chubb B and Whitaker J and Khunti K},
  year = {2026},
  journal = {Mayo Clinic proceedings},
  doi = {10.1016/j.mayocp.2026.10.021},
  url = {https://doi.org/10.1016/j.mayocp.2026.10.021}
}

RIS

TY  - JOUR
TI  - The Future Burden of Type 2 Diabetes and the Role of Glycaemic Control and GLP1-RAs.
AU  - Davies M
AU  - Padgett TE
AU  - Goulden S
AU  - McEwan P
AU  - Chubb B
AU  - Whitaker J
AU  - Khunti K
PY  - 2026
JO  - Mayo Clinic proceedings
DO  - 10.1016/j.mayocp.2026.10.021
UR  - https://doi.org/10.1016/j.mayocp.2026.10.021
ER  - 

APA

M, D., TE, P., S, G., P, M., B, C., J, W., & K, K. (2026). The Future Burden of Type 2 Diabetes and the Role of Glycaemic Control and GLP1-RAs.. Mayo Clinic proceedings. https://doi.org/10.1016/j.mayocp.2026.10.021

Source records